PubMed

Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal.

Faunce TA.

Aust New Zealand Health Policy. 2007 Jun 1;4:9.PMID: 17543114 [PubMed]Related articlesFree article

Assessing the impact of the Australia-United States Free Trade Agreement on Australian and global medicines policy.

Faunce T, Doran E, Henry D, Drahos P, Searles A, Pekarsky B, Neville W.

Global Health. 2005 Oct 6;1:15.PMID: 16209703 [PubMed]Related articlesFree article

Will the Australia-United States Free Trade Agreement undermine the Pharmaceutical Benefits Scheme?

Harvey KJ, Faunce TA, Lokuge B, Drahos P.

Med J Aust. 2004 Sep 6;181(5):256-9.PMID: 15347273 [PubMed - indexed for MEDLINE]Related articlesFree article

The UNESCO Bioethics Declaration 'social responsibility' principle and cost-effectiveness price evaluations for essential medicines.

Faunce TA.

Monash Bioeth Rev. 2005 Jul;24(3):10-9.PMID: 16302317 [PubMed - indexed for MEDLINE]Related articles

Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia.

Morgan S, McMahon M, Greyson D.

Health Policy. 2008 Aug;87(2):133-45. Epub 2008 Mar 4.PMID: 18295927 [PubMed - indexed for MEDLINE]Related articles

Australian pharmaceutical policy: price control, equity, and drug innovation in Australia.

Doran E, Alexander Henry D.

J Public Health Policy. 2008 Apr;29(1):106-20.PMID: 18368023 [PubMed - indexed for MEDLINE]Related articles

The PBS in a globalised world: free trade and reference pricing.

Searles A.

Aust Health Rev. 2009 May;33(2):186-91.PMID: 19563307 [PubMed - in process]Related articles

Transparency in pricing arrangements for medicines listed on the Australian Pharmaceutical Benefits Scheme.

Robertson J, Walkom EJ, Henry DA.

Aust Health Rev. 2009 May;33(2):192-9.PMID: 19563308 [PubMed - in process]Related articles

The global biopharma industry and the rise of Indian drug multinationals: implications for Australian generics policy.

Löfgren H.

Aust New Zealand Health Policy. 2007 Jun 1;4:10.PMID: 17543115 [PubMed]Related articlesFree article

Policy challenges of nanomedicine for Australia's PBS.

Faunce TA.

Aust Health Rev. 2009 May;33(2):258-67.PMID: 19563314 [PubMed - in process]Related articles

Nanotherapeutics: new challenges for safety and cost-effectiveness regulation in Australia.

Faunce TA.

Med J Aust. 2007 Feb 19;186(4):189-91.PMID: 17309421 [PubMed - indexed for MEDLINE]Related articlesFree article

High prices for generics in Australia - more competition might help.

Bulfone L.

Aust Health Rev. 2009 May;33(2):200-14.PMID: 19563309 [PubMed - in process]Related articles

Reference pricing, generic drugs and proposed changes to the Pharmaceutical Benefits Scheme.

Searles A, Jefferys S, Doran E, Henry DA.

Med J Aust. 2007 Aug 20;187(4):236-9. Epub 2007 Jun 13. Review.PMID: 17564580 [PubMed - indexed for MEDLINE]Related articlesFree article

KSR v. Teleflex. Part 2: Impact of U.S Supreme Court Patent Law on Canadian and global systems-based innovation ecologies.

Bouchard RA.

Health Law J. 2007;15:247-94.PMID: 19702185 [PubMed - indexed for MEDLINE]Related articles

University contributions to the HPV vaccine and implications for access to vaccines in developing countries: addressing materials and know-how in university technology transfer policy.

Crager SE, Guillen E, Price M.

Am J Law Med. 2009;35(2-3):253-79.PMID: 19697749 [PubMed - indexed for MEDLINE]Related articles

The Pharmaceutical Benefits Scheme 2003-2004.

Harvey KJ.

Aust New Zealand Health Policy. 2005 Jan 12;2(1):2.PMID: 15679896 [PubMed - as supplied by publisher]Related articlesFree article

Developing competitive and sustainable Polish generic medicines market.

Simoens S.

Croat Med J. 2009 Oct;50(5):440-8.PMID: 19839067 [PubMed - indexed for MEDLINE]Related articlesFree article

'Linkage' pharmaceutical evergreening in Canada and Australia.

Faunce TA, Lexchin J.

Aust New Zealand Health Policy. 2007 Jun 1;4:8.PMID: 17543113 [PubMed]Related articlesFree article

Free trade in pharmaceuticals.

Outterson MK.

Med J Aust. 2004 Sep 6;181(5):260-1.PMID: 15347274 [PubMed - indexed for MEDLINE]Related articlesFree article

Canada's implementation of the Paragraph 6 Decision: is it sustainable public policy?

Cohen-Kohler JC, Esmail LC, Cosio AP.

Global Health. 2007 Dec 6;3:12.PMID: 18062821 [PubMed - in process]Related articlesFree article